NEW YORK, Sept. 7 (GenomeWeb News) - InterGenetics has completed construction on a new 11,000-square-foot headquarters and laboratory in Oklahoma City in preparation for what it expects to be high demand for its genetic-based OncoVue breast-cancer risk predictive test. The company anticipates will be available next month, the firm said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.